TD Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,000
Closed -$276K 1245
2024
Q4
$276K Buy
+3,000
New +$289K ﹤0.01% 1211
2018
Q3
Sell
-11,600
Closed -$388K 1442
2018
Q2
$388K Buy
+11,600
New +$413K ﹤0.01% 1316

Other funds holding LMAT

TD Asset Management's LMAT Position: Q1 2025 in Review

TD Asset Management sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 3,000 shares — an estimated $276K sold.

TD Asset Management first reported a position in LMAT in Q2 2018 and held it in 2 quarters. The position peaked at $388K in Q2 2018. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • TD Asset Management reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • TD Asset Management sold 3,000 LeMaitre Vascular shares in Q1 2025, an estimated $276K.
  • TD Asset Management first reported a position in LeMaitre Vascular in Q2 2018 and held it in 2 quarters.
  • TD Asset Management's LeMaitre Vascular position peaked at $388K in Q2 2018.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.